AAN 2026

April 18-22, 2026
Chicago, IL

The 78th Annual Meeting of the American Academy of Neurology
Explore more Neurology congress materials
Material Type

Results(6)

Neuroscience
Demographics and Clinical Factors Associated With Persistence on Cannabidiol (CBD) in US Patients With LennoxGastaut Syndrome (LGS), Dravet Syndrome (DS), Tuberous Sclerosis Complex (TSC), or Other Refractory Epilepsies
Author(s): Leah Burn, Vicki Osborne, Arthur Sillah et al.
An Assessment of Acute Pharmacodynamic Drug-Drug Interactions (PD DDIs) Between Cannabidiol (CBD) and Cenobamate (CNB) in a Mouse Model of Generalized Tonic Seizures
Author(s): Rohini R. Rana, William H. Hind, Pabitra H et al.
Cannabidiol Efficacy in Patients With Lennox-Gastaut Syndrome With Developmental and Epileptic Encephalopathy–Associated Genetic Variants: A Subgroup Analysis
Author(s): Elizabeth A. Thiele, Michael Boffa, Daniel Checketts et al.
Tuberous Sclerosis Complex –Associated Neuropsychiatric Disorders Outcomes Following Adjunctive Cannabidiol Treatment: 6 - Month Intermediate Analysis of the EpiCom Trial
Author(s): Agnies van Eeghen, Sarah M.L. Wilson, Elizabeth A. Thiele et al.
Phase 1, Open-Label, Fixed-Sequence, Bidirectional, Pharmacokinetic (PK) Drug-Drug Interaction (DDI) Study Between Cannabidiol (CBD) and Cenobamate (CNB) in Healthy Adult Participants
Author(s): Arjun Vijan, Hongwei Xue, Patricia Chandler et al.
Changes in Self-Reported Cognitive Complaints, Functional Impairments, Work Productivity, and Symptom Severity in Participants With Narcolepsy After Treatment With Greater Than 9 Gram Dosages of Low-Sodium Oxybate in the DUET Study
Author(s): Logan D. Schneider, MD, Chad M. Ruoff, MD, David T. Plante, MD, PhD et al.